description) Many industrial and environmental chemicals mimic, antagonize, or indirectly alter the activity of hormones, particularly steroid hormones. In women, these chemicals mainly affect the activity of estrogens. It is commonly thought that these chemicals bind to the estrogen receptor, either imitating the action of the hormone or blocking its activity. However, it is also possible that some of these compounds may act in an indirect fashion by either inhibiting aromatase activity or inducing aromatase expression, resulting in a change in the level of estrogen in women. Aromatase is a cytochrome P450 enzyme that synthesizes estrogen. Preliminary results have been obtained to indicate that phytoestrogens and organochlorine compounds can act as endocrine disrupters in women by modifying the level of estrogen through altering either the activity of aromatase or the expression of the enzyme. Experiments will be carried out to provide a molecular and mechanistic basis as to how phytoestrogens and organochlorine compounds affect estrogen biosynthesis (i.e., aromatase function) in women. The structural requirement for the compounds to modify the catalytic properties of aromatase will be determined by computer modeling and by evaluation of their interactions with aromatase mutants. In addition, the effects of phytoestrogens and organochlorine compounds on aromatase expression throughout critical periods of exposure (neonatal, premenopausal, pregnant, and postmenopausal) will be investigated using cell culture studies with cell lines that utilize different promoters for aromatase expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES008258-02
Application #
2770788
Study Section
Special Emphasis Panel (ZES1-CKS-B (M1))
Project Start
1996-09-01
Project End
1999-12-31
Budget Start
1998-09-01
Budget End
1999-12-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
City
Duarte
State
CA
Country
United States
Zip Code
91010
Kanaya, Noriko; Nguyen, Duc M; Lu, Hannah et al. (2015) AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens. Breast Cancer Res Treat 151:335-45
Chen, Zhike; Yuan, Yate-Ching; Wang, Yuanzhong et al. (2015) Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer. Breast Cancer Res Treat 152:29-39
Chen, Zhike; Wang, Yuanzhong; Warden, Charles et al. (2015) Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells. J Steroid Biochem Mol Biol 149:118-27
Chen, Zhike; Wang, Ou; Nie, Min et al. (2015) Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism. Mol Cell Endocrinol 399:32-42
Twardowski, Przemyslaw; Kanaya, Noriko; Frankel, Paul et al. (2015) A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus-induced prostate-specific antigen responses. Cancer 121:2942-50
Kai, Masaya; Kanaya, Noriko; Wu, Shang V et al. (2015) Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin. Breast Cancer Res Treat 151:281-94
Kanaya, Noriko; Vonderfecht, Steven; Chen, Shiuan (2013) Androgen (dihydrotestosterone)-mediated regulation of food intake and obesity in female mice. J Steroid Biochem Mol Biol 138:100-6
Kubo, Makoto; Kanaya, Noriko; Petrossian, Karineh et al. (2013) Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat). Breast Cancer Res Treat 137:93-107
Wong, Cynthie; Wang, Xin; Smith, David et al. (2012) AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies. Breast Cancer Res Treat 134:671-81
Wong, Cynthie; Chen, Shiuan (2012) The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistance. J Steroid Biochem Mol Biol 131:83-92

Showing the most recent 10 out of 68 publications